Nuvalent Inc
Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer. Its lead product candidates are NVL-520, a novel ROS1-selective inhibitor to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of ROS1 tyrosine kinase inhibitor… Read more
Nuvalent Inc (NUVL) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.083x
Based on the latest financial reports, Nuvalent Inc (NUVL) has a cash flow conversion efficiency ratio of -0.083x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-70.46 Million) by net assets ($845.40 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nuvalent Inc - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Nuvalent Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nuvalent Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nuvalent Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Outfront Media Inc
NYSE:OUT
|
0.161x |
|
Janus Henderson Group PLC
NYSE:JHG
|
-0.014x |
|
Punjab National Bank
NSE:PNB
|
0.033x |
|
Tokyu Fudosan
F:T8F
|
0.070x |
|
Ackermans & Van Haaren NV
PINK:AVHNF
|
0.121x |
|
Kingnet Network Co Ltd
SHE:002517
|
0.057x |
|
Fastighets AB Balder (publ)
PINK:BALDF
|
0.010x |
|
SHENWAN HONGYUAN GR.H YC1
F:2X2A
|
N/A |
Annual Cash Flow Conversion Efficiency for Nuvalent Inc (2019–2024)
The table below shows the annual cash flow conversion efficiency of Nuvalent Inc from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.07 Billion | $-185.06 Million | -0.173x | -21.51% |
| 2023-12-31 | $700.56 Million | $-99.74 Million | -0.142x | -1.45% |
| 2022-12-31 | $462.98 Million | $-64.97 Million | -0.140x | 0.00% |
| 2021-12-31 | $285.04 Million | $-40.00 Million | -0.140x | -129.40% |
| 2020-12-31 | $-31.32 Million | $-14.95 Million | 0.477x | -14.56% |
| 2019-12-31 | $-17.26 Million | $-9.64 Million | 0.559x | -- |